DM
TLSI icon

Deerfield Management’s TriSalus Life Sciences TLSI Stock Holding History

Deerfield Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$6 – 637
2024
Q2 		$6 Hold
1
– – ﹤0.01% 433
2024
Q1 		$10 Hold
1
– – ﹤0.01% 367
2023
Q4 		$8 Hold
1
– – ﹤0.01% 222
2023
Q3 		$5 Buy
+1
New +$8 ﹤0.01% 88
2022
Q4 		– Sell
-999,999
Closed -$9.93M – 122
2022
Q3 		$9.93M Hold
999,999
– – 0.2% 85
2022
Q2 		$9.85M Hold
999,999
– – 0.2% 80
2022
Q1 		$9.8M Hold
999,999
– – 0.22% 74
2021
Q4 		$9.88M Hold
999,999
– – 0.21% 84
2021
Q3 		$9.93M Buy
+999,999
New +$9.79M 0.19% 92

Other funds holding TLSI

WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32M AUM 108.13% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management's TLSI Position: Q3 2024 in Review

Deerfield Management sold out of TriSalus Life Sciences (TLSI) in Q3 2024, closing a stake of 1 share — an estimated $6 sold.

Deerfield Management first reported a position in TLSI in Q3 2021 and held it in 9 quarters. The position peaked at $9.93M in Q3 2022. 32 funds tracked by Wall St. Rank hold TLSI as of Q3 2024.

  • Deerfield Management reported no remaining TriSalus Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 1 TriSalus Life Sciences share in Q3 2024, an estimated $6.
  • Deerfield Management first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 9 quarters.
  • Deerfield Management's TriSalus Life Sciences position peaked at $9.93M in Q3 2022.
  • 32 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.